Volume 1, Issue 2 pp. 65-72
Article
Full Access

Animal model for investigation of fluphenazine kinetics after administration of long-acting esters

A. C. Altamura

A. C. Altamura

Department of Pharmacology and Therapeutics, The London Hospital Medical College, London, El 2AD, U.K.

Search for more papers by this author
R. Whelpton

R. Whelpton

Department of Pharmacology and Therapeutics, The London Hospital Medical College, London, El 2AD, U.K.

Search for more papers by this author
S. H. Curry

Corresponding Author

S. H. Curry

Department of Pharmacology and Therapeutics, The London Hospital Medical College, London, El 2AD, U.K.

Department of Pharmacology and Therapeutics, The London Hospital Medical College, London, El 2AD, U.K.Search for more papers by this author
First published: October/December 1979
Citations: 11

Abstract

A model was developed for studying fluphenazine availability and disposition. Rats were given doses of radioactively labelled esters of fluphenazine by intramuscular injection. Radioactivity excreted in urine, faeces, and expired air was assessed for fluphenazine esters, fluphenazine, and CO2 content. Levels of fluphenazine and its esters were measured in plasma, brain, and muscle (injected and non-injected samples). The data mimicked those obtained in other studies involving the same material given to human subjects, and posed new questions concerning the factors controlling fluphenazine availability when given as ‘long-acting’ intramuscular injections.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.